Monopar Therapeutics (MNPR) Cash from Operations (QoQ) (2017 - 2025)
Monopar Therapeutics (MNPR) Cash from Operations (QoQ) (2017 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Monopar Therapeutics | 707.36 Mn | 645.53 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -61.21% |
| Sep 30, 2025 | -94.04% |
| Jun 30, 2025 | 80.98% |
| Mar 31, 2025 | -183.39% |
| Dec 31, 2024 | -86.16% |
| Sep 30, 2024 | 35.98% |
| Jun 30, 2024 | -1.29% |
| Mar 31, 2024 | -7.08% |
| Dec 31, 2023 | 20.31% |
| Sep 30, 2023 | 7.69% |
| Jun 30, 2023 | 7.47% |
| Mar 31, 2023 | -74.46% |
| Dec 31, 2022 | 39.41% |
| Sep 30, 2022 | -63.91% |
| Jun 30, 2022 | 46.88% |
| Mar 31, 2022 | -21.44% |
| Dec 31, 2021 | -4.67% |
| Sep 30, 2021 | -38.06% |
| Jun 30, 2021 | 27.45% |
| Mar 31, 2021 | -56.21% |